Harvard Bioscience Inc vs. Waters Corp
Waters Corp (WAT) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| HBIO | WAT | |
|---|---|---|
| Market Cap | $34.37 million | $40.36 billion |
| Revenue (TTM) | $87.81 million | — |
| Net Income (TTM) | $-10,412,000 | — |
WAT leads on 1 of 1 size & scale factors.
Valuation
| HBIO | WAT | |
|---|---|---|
| Price / Book | 4.63 | 2.66 |
| Price / Sales | 0.39 | — |
WAT leads on 1 of 1 valuation factors.
Profitability
| HBIO | WAT | |
|---|---|---|
| Net Margin | -11.86% | — |
| Return on Equity | -140.36% | — |
HBIO and WAT split the profitability factors evenly.
Risk & Sentiment
| HBIO | WAT | |
|---|---|---|
| Short Interest | 11.71% | 3.23% |
WAT leads on 1 of 1 risk & sentiment factors.
Dig deeper: HBIO overview, HBIO financials, WAT overview, WAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.